US 11426393
Prolyl hydroxylase inhibitors and methods of use
granted A61KA61K31/4418A61K31/4433
Quick answer
US patent 11426393 (Prolyl hydroxylase inhibitors and methods of use) held by Akebia Therapeutics, Inc. expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Akebia Therapeutics, Inc.
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/4418, A61K31/4433, A61P, A61P1/04